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Abstract
Background: Highly multiplexed assays for quantitation of RNA transcripts are being used in many areas of biology
and medicine. Using data generated by these transcriptomic assays requires measurement assurance with
appropriate controls. Methods to prototype and evaluate multiple RNA controls were developed as part of the
External RNA Controls Consortium (ERCC) assessment process. These approaches included a modified Latin square
design to provide a broad dynamic range of relative abundance with known differences between four complex
pools of ERCC RNA transcripts spiked into a human liver total RNA background.
Results: ERCC pools were analyzed on four different microarray platforms: Agilent 1- and 2-color, Illumina bead,
and NIAID lab-made spotted microarrays; and two different second-generation sequencing platforms: the Life
Technologies 5500xl and the Illumina HiSeq 2500. Individual ERCC controls were assessed for reproducible
performance in signal response to concentration among the platforms. Most demonstrated linear behavior if they
were not located near one of the extremes of the dynamic range. Performance issues with any individual ERCC
transcript could be attributed to detection limitations, platform-specific target probe issues, or potential mixing
errors. Collectively, these pools of spike-in RNA controls were evaluated for suitability as surrogates for endogenous
transcripts to interrogate the performance of the RNA measurement process of each platform. The controls were
useful for establishing the dynamic range of the assay, as well as delineating the useable region of that range
where differential expression measurements, expressed as ratios, would be expected to be accurate.
Conclusions: The modified Latin square design presented here uses a composite testing scheme for the evaluation
of multiple performance characteristics: linear performance of individual controls, signal response within dynamic
range pools of controls, and ratio detection between pairs of dynamic range pools. This compact design provides
an economical sample format for the evaluation of multiple external RNA controls within a single experiment per
platform. These results indicate that well-designed pools of RNA controls, spiked into samples, provide
measurement assurance for endogenous gene expression studies.
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Background
In 2003, the National Institute of Standards and Technol-
ogy (NIST) hosted a meeting to discuss the need for a uni-
versal RNA reference material, which could be used for
gene expression profiling assays [1]. As a result of this ef-
fort, the External RNA Controls Consortium (ERCC) was
formed, of which NIST is a founding member and host.
The ERCC assembled a sequence library of 176 DNA
sequences that could be transcribed into RNA to serve as
controls in systems used to measure gene expression
[2, 3]. These controls were cataloged as ERCC-00001
through ERCC-00176, and are collectively referred to as
ERCC controls in this manuscript. These were evaluated
and a subset was selected for dissemination as a standard.
A set of 96 controls are now available as a set of sequence-
certified DNA plasmids, NIST Standard Reference Material
(SRM) 2374 [4].
In the final phase of evaluation, an experimental de-
sign for assessing the combined performance of ERCC
controls prepared as complex RNA pools was used. Each
ERCC subpool was designed to have a 220 dynamic range
of abundance of controls, and particular controls in the
different pools were present in different abundances ac-
cording to a modified Latin square design. This design
provides known relative differences between the pools
across a large dynamic range of abundance (Fig. 1). With
this design, individual ERCC controls were assessed for
their signal response to 1.5-, 2.5-, and 4-fold increases in
concentration. Pairwise comparisons of these pools also
provide for an assessment of ratio-based performance as a
function of dynamic range. Initially assessed with three
different microarray platforms, these same pools were
subsequently measured by RNA sequencing (RNA-Seq)
with two second-generation (NGS) sequencing platforms.
The data from these two sets of experiments, correspond-
ing to the 96 controls of the SRM, are presented here.
Methods
Pool design
The ERCC controls were distributed into 5 subpools
(A-E), each containing a unique set of controls (see
Table 1). These subpools were prepared at AIBioTech
(formerly CBI Services, Richmond, VA) to ERCC specifi-
cations. This design results in the relative abundance
within each subpool covering a dynamic range of 220. Sub-
pools A-E were then mixed by volume in a modified Latin
square design to create 4 different pools (see Fig. 1 and
Table 1). Subpools B-E have different relative abundances
between the four pools (in a Latin square design), while
subpool A is held at a constant proportion (the “modifica-
tion”). In addition, the ERCC controls in subpools B-E
participate in 6 pairwise comparisons between pools to
produce ratios of 4-, 2.7-, 2.5-, 1.7-, 1.6-, and 1.5-to-1
(Fig. 1 and Additional file 1: Figure S1, Additional file 2:
Figure S2, Additional file 3: Figure S3, Additional file 4:
Figure S4, Additional file 5: Figure S5 and Additional file
6: Figure S6). The ERCC controls in subpool A are always
present at 10 % in any of the pools, and create the 1-to-1
component in any of the 6 possible pairwise comparisons.
These pools were designated as Pools 12, 13, 14, and 15 in
the set of pools developed for ERCC testing [2]. Each pool
was spiked into a common “background” of human liver
total RNA (Ambion) to create 4 corresponding samples.
Each microarray test site determined the relative amount
Fig. 1 Modified Latin square pool design. Five subpools of ERCC controls, each containing a unique set of transcripts at different target relative
abundance (see Table 1), were combined in varying proportions. Subpools A, B, C, D, and E are shaded, black, white, light grey, medium grey,
and dark grey, respectively. Subpool A is present as a constant 10 % component of each pool, the modification. Subpools B-E are mixed using a
Latin square of proportions 10, 15, 25, and 40 %
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Table 1 Distribution of ERCCs among subpools and pools
Target Relative Abundance
Control ID Subpool Pool 12 Pool 13 Pool 14 Pool 15 Note
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of spike-in pools to add to the background. Agilent,
Illumina, and NIAID used 0.144, 0.25, and 0.265 %
(wt/wt) of ERCC pool per total liver RNA, respectively.
For the sequencing test sites total RNA samples were
spiked at NIST at 0.3 % (wt/wt) and then sequenced by
NIST and Illumina.
The ERCC molecules used in these pools were pre-
pared by in vitro transcription of polymerase chain
reaction (PCR) products representing candidate se-
quences prior to the release of NIST SRM 2374. The
plasmids were designed to produce either “sense” or
“antisense” RNA controls [4]. In this study, seven of
these ERCC transcripts were determined to be anti-
sense using a stranded RNA-Seq protocol (see Table 1)
and were excluded from further data analysis, because
the microarrays were designed to detect sense RNA
controls.
Microarray measurements
Samples were measured at each test site using the
following methods.
The NIAID in-house spotted microarrays contain long
(70-mer) oligonucleotides designed to hybridize the
ERCC transcripts printed on epoxy-coated glass slides
(Corning) in quadruplicate using an OmniGrid robot
(Genomic Solutions) with 16 SMP3 print tips (Telechem).
RNA was reverse transcribed using Oligo dT primer
(12–20 mer) mix (Invitrogen) and Superscript II reverse
transcriptase (Invitrogen). Fluorescent Cy-Dye-dUTP
(GE) nucleotide was incorporated into first-strand cDNA
during the reverse transcription. After degradation of the
mRNA template strand, labeled single-stranded cDNA
target was purified using Vivaspin 500 (10 K, Millipore).
Hybridization was performed at 45 C°, for 16 h on a MAUI
hybridization station. The arrays were washed twice in 1X
SSC and 0.05 % SDS and twice in 0.1X SSC, then air dried.
Microarrays were scanned on GenePix 4000B (Axon)
at 10 μm resolution. GenePix Pro software was used
for image analysis. Median pixel intensity (no background
subtraction) was taken for each of the 4 replicate spots,
the median of these four values was taken to repre-
sent the data.
The Agilent microarrays (8x60K Agilent G3 8-pack
format with the Design ID 022439) contain 60-mer
oligonucleotide probes synthesized in situ onto slides
using a proprietary non-contact industrial inkjet printing
process. Labeled cRNA for both the one-color and two-
color microarray experiments was prepared using the
Agilent Low Input Quick Amp Labeling Kit, Two-Color
(5190-2306). RNA was reverse transcribed using Affini-
tyScript RT, Oligo(dT) Promoter Primer, and T7 RNA
Polymerase. Fluorescent Cy-Dye-dCTP nucleotide was
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incorporated during cRNA synthesis and amplification.
Microarrays were hybridized at 65 °C for 17 h. All
microarrays were scanned in one batch in random
order using default settings for Agilent C Scanner using
a single pass over the scan area at a resolution of 3 μm
and a 20-bit scan type. Data was extracted with Agilent
Feature Extraction Software (ver. 10.7.3.1) using the
default settings for either the one-color protocol or the
two-color protocol.
The Illumina Human-6 Expression BeadChips contain
50-mer oligonucleotide probes with a 29-mer address se-
quences attached to beads held in etched microwells.
RNA was reverse transcribed using a T7 Oligo(dT) primer
containing a T7 promoter sequence. Biotinylated cRNA
was prepared using the Illumina TotalPrep RNA Amplifi-
cation Kit (Ambion). BeadChips were hybridized at 58 °C
for 14–20 h, washed, and labeled with streptavidin-Cy3.
BeadChips were scanned with the Illumina iScan System.
Intensity values are determined for every bead and sum-
marized for each bead type. For more details refer to the
Whole-Genome Gene Expression Direct Hybridization
Assay Guide (Illumina, part no. 11322355).
RNA sequencing measurements
NIST prepared samples of spiked liver total RNA for se-
quencing analysis with the 5500xl at NIST and the HiSeq
2500 at Illumina. Prior to library preparation samples
were depleted of ribosomal RNA. The 5500xl experi-
ment produced an average of 23,866,495 single-ended
reads (75 base) per sample and the HiSeq 2500 experi-
ment yielded an average of 48,168,710 paired-end reads
(2 x 75 base). For both platforms sequence reads were
aligned against a reference sequence consisting of the
human genome (hg19) and the ERCC transcript se-
quences of SRM 2374 (Note: ERCC-00114 is not part of
the SRM and not included as part of the reference tran-
scriptome). Alignment and quantification of sequence
reads to obtain per transcript counts was performed
with the LifeScope bioinformatic analysis suite (Life
Technologies) for 5500xl data and the Tophat-Cufflinks
suite was used for HiSeq 2500 data [5, 6].
Results and discussion
For each of the platforms, if the ERCC spike-in pools are
added to the background RNA in the proper proportion,
then the 220 range of relative abundance will cover the
distribution of the endogenous transcript signals. In the
first set of experiments, each microarray platform pro-
vider empirically determined in pilot studies its chosen
spike-in proportion to add to the total RNA background
(not shown). Agilent used 0.144 % (wt/wt) for both one-
color and two-color arrays, and Illumina and NIAID
used 0.25, and 0.265 %, respectively. For the RNA-Seq
experiments, ERCC pools were added to the background
at NIST at 0.3 % and shared with the Illumina site. The
LifeTech 5500xl and Illumina HiSeq measurements were
performed at NIST and Illumina, respectively. The distri-
bution of ERCC signals relative to the endogenous liver
background transcripts are shown for all platforms in
Table 2. For all sites, the dynamic range of the signals
from the controls matched the range of signal expres-
sion from the endogenous genes of the liver background.
Table 2 Dynamic range coverage
Platform Units Subset ERCC-00073 Minimum Maximum Range
Illumina log2 signal ERCC 5.81 ± 0.08 5.72 ± 0.07 13.88 ± 0.11 8.16 ± 0.13
Bead BKGDa 5.35 ± 0.07 14.34 ± 0.08 8.99 ± 0.10
NIAID log2 signal ERCC 5.53 ± 0.02 5.53 ± 0.03 15.83 ± 0.38 10.30 ± 0.39
In-house BKGD 5.20 ± 0.01 15.26 ± 0.27 10.06 ± 0.27
Agilent log2 signal ERCC 2.62 ± 0.14 2.57 ± 0.16 20.73 ± 0.18 18.16 ± 0.24
One-color BKGD 2.41 ± 0.10 20.66 ± 0.06 18.25 ± 0.12
Agilent log2 signal ERCC 2.57 ± 0.06 2.40 ± 0.06 18.37 ± 0.10 15.98 ± 0.12
Two-color BKGD 4.40 ± 0.15 20.00 ± 0.10 15.60 ± 0.19
Illumina log2 FPKM ERCC Undetected −4.98 ± 0.67 14.58 ± 0.27 19.56 ± 0.72
HiSeq BKGD −6.34 ± 0.40 18.27 ± 0.05 24.61 ± 0.40
LifeTech log2 RPKM
b ERCC Undetected −3.26 ± 0.38 16.47 ± 0.34 19.73 ± 0.51
SOLiD BKGD −6.64 ± 0.00 17.30 ± 0.35 23.94 ± 0.35
aAll transcripts measured in the total human liver RNA background
bMinimum RPKM value reported is truncated at 0.01 for all replicates
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This supports the use of these signals to derive metrics
useful for characterizing each measurement system (see
Additional files 7, 8, 9, 10, 11 and 12 for ERCC data).
Dose-response and outlier detection
For each platform, we can determine whether the analytical
signal (fluorescence intensity in microarrays or length nor-
malized counts in sequencing) changes with the concentra-
tion of an analyte (the ERCC being measured). For each
control, the signal from each pool can be plotted against the
corresponding relative abundance (Table 1), producing a
collection of dose-response curves representing each indi-
vidual ERCC in the study (Figs. 2, 3, 4, 5, 6 and 7, panel a).
ERCC controls that were missing data for one or more con-
centrations in the RNA-Seq experiments were flagged as
partially detected or undetected, and excluded from further
analysis (Figs. 6 and 7, panel a). The mid-point of each
ERCC dose-response curve (average signal versus average
relative abundance from the Latin square) was used to as-
sess whether any particular ERCC was an outlier relative to
the entire set of controls. The data were fit to an appropriate
model for each platform (Figs. 2, 3, 4, 5, 6 and 7, panel b).
A B
C D
Fig. 2 ERCC signal response as a function of relative abundance in each of the four pools on the Illumina microarray platform. In Panel a, each
line represents an individual ERCC control, where grey = titrated, black = 1-to-1, red = outlier, and dashed-line = background (average ERCC-00073).
In Panel b, the centroid of each ERCC control is plotted, where the red line corresponds to the fitted Langmuir model, open circles = within 99 %
CI, red circles = outliers, and dashed-line = background. In Panel c, the slope of each ERCC is plotted, where the red line corresponds to expected
slope (first derivative of the Langmuir model), the vertical dotted lines correspond to the margins of the linear region (inflection points of the first
derivative of the Langmuir model), the open circles =monotonic ERCC controls (ρ = 1), grey squares = non-monotonic, and red = outliers. Numbers
adjacent to outliers in Panels b and c correspond to the last three digits of the Control ID in Table 3. In Panel d, each ERCC control is represented on
the Bland-Altman plot of Pool 12 vs Pool 14, where the red line corresponds to the ratio versus average intensity derived from the fitted Langmuir
model, with outliers coded as in Panels b and c above
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For the microarray experiments, a model using the
Langmuir isotherm was used [7, 8]. The dissociation con-
stant, Kd, was determined by fitting the data as follows:
I ¼ lmaxC
Kd þ Cð Þ þ bg ð1Þ
Where the maximal intensity of a feature at saturation,
Imax, and the background, bg, are experimentally derived
from the average of the most abundant ERCC in each of
the 4 pools and ERCC-00073, a component omitted
from the pools, respectively. For the RNA-Seq experi-
ments, a linear fit with a slope of 1 and fitted y-intercept
was used as the model. For either model, ERCC controls
outside the 99 % confidence interval (CI) were flagged as
outliers (Figs. 2, 3, 4, 5, 6 and 7, panel b) and compared
across platforms to identify any ERCC-specific anomalies
(Table 3).
With the exception of the ERCC controls in the 1-to-1
subpool, the signal for each control should follow a
strictly increasing monotonic function determined by
the pool fraction of the Latin square design, 10 % <
15 % < 25 % < 40 %, (see Fig. 1). This monotonicity
was assessed with Spearman’s rho, ρ, where ERCC
controls with ρ < 1 were identified for comparison
across platforms.
In addition, the slope of each individual ERCC
dose-response curve can be calculated and plotted as
a function of the relative abundance, where the slope
(m = 1) corresponds to an ideal dose-response. For
the microarray data, the first derivative of the Lang-
muir function also provides us with a model of the
expected slope and the inflection points allow us to
A B
C D
Fig. 3 ERCC signal response as a function of relative abundance in each of the four pools on the NIAID microarray platform. See Fig. 2 legend
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demarcate a region of the dynamic range where we
should expect a linear response (Figs. 2, 3, 4, 5, 6 and
7, panel c) [9]. Non-monotonic ERCC controls that
fall within that portion of the dynamic range were
also identified as outliers. For the RNA-Seq data, all
non-monotonic ERCC controls are flagged as outliers
(Figs. 6 and 7, panel c). One control, ERCC-00113,
was an outlier on all platforms, with ρ = −0.2 for
each. Closer inspection of the monotonic trend indi-
cated that the least abundant target feature produced
the highest signal in each case. This ERCC was more
consistent with membership in subpool C, indicating a
likely error in the preparation of the subpools. Therefore,
Figs. 2, 3, 4, 5, 6 and 7 include this ERCC plotted as a
component of subpool C.
Table 3 includes all ERCC identified as outliers by the
two criteria above and highlighted in Figs. 2, 3, 4, 5, 6
and 7 and specific controls discussed below are indicated
with an asterisk (*). The majority of non-monotonic
ERCC controls in the microarray experiments occurred
below the lower inflection point on the slope plots and
those flagged for non-detection in the RNA-Seq experi-
ments also appear in the lower range of the signal re-
sponse curves. For these ERCC controls, it is difficult to
assess performance beyond their utility for defining the
lower limits of the linear range, so these are not included
in the outlier table.
There were nine controls that were outliers on at least
one platform for each criteria. Six of those were outliers
for both criteria on the same platform: ERCC-00156 on
LifeTech; ERCC-00131, ERCC-00134 and ERCC-00143 on
AGL-1; ERCC-00148 on AGL-1 and ILM HiSeq; and
ERCC-00168 on AGL-2 and ILM HiSeq. All of these con-
trols performed well on the majority of platforms.
A B
C D
Fig. 4 ERCC signal response as a function of relative abundance in each of the four pools on the Agilent 1-color microarray platform. See Fig. 2 legend
Pine et al. BMC Biotechnology  (2016) 16:54 Page 8 of 15
Fifteen ERCC controls were non-monotonic only.
ERCC-00046 and ERCC-00062 were the most highly
abundant outliers in this class. In both cases, the two low-
est concentrations for each control produced nearly iden-
tical values where the lowest concentration is slightly
higher. With the exception of ERCC-00138, all of these
controls performed well on the majority of platforms.
There are 26 ERCC controls that appear to be outliers
with respect to the overall dose-response model that are
still monotonic. For example, ERCC-00058 was the only
control to be determined a response curve outlier on
all microarray platforms and one RNA-Seq platform,
however the observed slope on all platforms tested
was greater than 0.9. ERCC-00170 was also flagged
on every platform except the NIAID microarray, but
was not evaluated for montonicity because it is in the
1-to-1 subpool.
Some of these results may be attributable to difficulties
with accurately preparing large dynamic range pools
with multiple controls, so that the actual concentration
is different than the nominal abundance. The linear sig-
nal responses observed within the Latin square design
indicate that the proper combination of subpools A-E
was achieved. Some of these outliers might also be the
result of an RNA processing bias that may be analyte
specific and proportional to abundance, for example
poly-A enrichment [10].
Intensity-dependent differential expression
For microarray data, an intensity-dependent bias is
often visualized using an MA-plot; where M is the log2
transformation of the ratio of red and green fluores-
cence intensities in 2-channel data, and A is the log2
transformation of the average of the two [11]. This view
A B
C D
Fig. 5 ERCC signal response as a function of relative abundance in each of the four pools on the Agilent 2-color microarray platform. See Fig. 2 legend
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has also been applied to two-condition single channel
data, where M becomes the ratio of two different con-
ditions, which is also referred to as a ratio-intensity plot
(RI-plot) [12]. These comparative visualizations have
been extended to sequencing data in the form of RA-
plots, where the ratios and averages of integer count
data form a characteristic pattern at the lower end of
the signal range [13]. Each of these visualizations is a
variation of a Bland-Altman plot (or difference plot),
which is used here to visualize the ability to detect
the nominal differences between two measurements
[14]. A Bland-Altman plot of the ERCC components
can be generated for any pairwise combination of Pools
12–15. One possible pairwise comparison, which produces
fold-changes of 2.5 and 2.7 in both “up” and “down”
directions (see Fig. 1) is shown in Figs. 2, 3, 4, 5, 6
and 7, panel d. Additional pairwise comparisons are
shown in Additional file 1: Figure S1, Additional file 2:
Figure S2, Additional file 3: Figure S3, Additional file 4:
Figure S4, Additional file 5: Figure S5 and Additional file 6:
Figure S6.
For the microarray platforms, the discrimination
between the target ratios is optimal near the middle
of their dynamic range, and the ratios are
A B
C D
Fig. 6 ERCC signal response as a function of relative abundance in each of the four pools on the LifeTech NGS platform. In Panel a, each line
represents an individual ERCC control, where grey = titrated, black = 1-to-1, and red = outlier. Partially detected and undetected ERCC controls are
included at the bottom to indicate their targeted relative abundance. In Panel b, the centroid of each ERCC control is plotted, where the red line
corresponds to the linear fitted model, open circles = within 99 % CI, and red circles = outliers. In Panel c, the slope of each ERCC is plotted,
where the open circles = monotonic ERCC controls (ρ = 1), grey squares = non-monotonic, and red = outliers. Numbers adjacent to outliers in
Panels b and c correspond to the last three digits of the Control ID in Table 3. In Panel d, each ERCC control is represented on the Bland-Altman
plot of Pool 12 vs Pool 14, with outliers coded as in Panels b and c above
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“compressed” at both the lower and upper extremes.
This constraint upon log2 ratios has been previously
described [15]. The ratios converge towards unity at
lower end due to background noise, which is additive,
and contributes to both samples being compared. A
similar compression is seen at high signal, where
saturation dominates. We can also use Equation 1 to
derive the expected intensity ratios and average inten-
sities for any fold-change of relative abundance. These
fitted curves are also shown in Figs. 2, 3, 4 and 5,
panel d.
Signals in RNA-Seq are not subject to saturation
(though high abundance transcripts can dominate the
counting, and “crowd out” signals from lower abundance
controls). As a consequence, the ratios do not compress
at the upper end of the dynamic range. The RNA-Seq
signals in this dataset are derived from counting
technical replicates, where the variation can be char-
acterized by a Poisson distribution [16]. In this case,
“shot noise” dominates the signal at the low end,
where counts might be added to either sample, and
the ratios may deviate from target values in either
direction (Figs. 6 and 7, panel d).
Conclusions
The modified Latin square design provided for simultan-
eous evaluation of multiple controls with a minimal
number of samples. While each individual ERCC control
was only tested over a small range of relative abundance,
up to 4-fold for the ERCC controls tested at multiple ra-
tios and a single relative abundance value for the 1-to-1
components, in aggregate, they describe the overall
measurement behavior of a platform.
A B
C D
Fig. 7 ERCC signal response as a function of relative abundance in each of the four pools on the Illumina NGS platform. See Fig. 6 legend
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Table 3 ERCC outliers grouped by performance criteria
Log2 Target Response Curve Outliers Non-monotonic
Controls Relative Abundance Subpool AGLa ILM NIAID LifeTech ILM HiSeq AGLa ILM NIAID LifeTech ILM HiSeq
ERCC-00156b 1 B ◯ ◯
ERCC-00147 2 C ◯ ◯ ◯
ERCC-00148b 2 D ◯[1,2] ◯ ◯[1] ◯ ◯
ERCC-00137 3 B ◯[2] ◯[1] ◯
ERCC-00143b 3 E ◯[1] ◯[1]
ERCC-00131b 4 D ◯[1] ◯ ◯[1,2]
ERCC-00134b 4 E ◯[1] ◯[1,2]
ERCC-00168b 6 E ◯[1,2] ◯ ◯[2] ◯ ◯
ERCC-00095 8 E ◯
ERCC-00157 1 C ◯
ERCC-00158 1 D ◯[1]
ERCC-00160 1 E ◯[1]
ERCC-00145 2 B ◯[1]
ERCC-00150 2 E ◯[1]
ERCC-00138b 3 C ◯[1,2] ◯ ◯
ERCC-00142 3 D ◯[2] ◯
ERCC-00128 4 B ◯[2] ◯
ERCC-00111 6 C ◯
ERCC-00097 7 B ◯
ERCC-00098 7 C ◯ ◯
ERCC-00104 7 E ◯
ERCC-00086 8 C ◯ ◯
ERCC-00062b 12 C ◯
ERCC-00046b 13 C ◯
ERCC-00162 0 A ◯[1]
ERCC-00126 4 A ◯
ERCC-00113b 5 C ◯[2] ◯ ◯
ERCC-00117 5 C ◯
ERCC-00120 5 D ◯
ERCC-00109 6 B ◯ ◯ ◯
ERCC-00077 8 A ◯
ERCC-00081 9 D ◯
ERCC-00060 10 A ◯
ERCC-00075 10 D ◯
ERCC-00171 10 B ◯
ERCC-00054 11 B ◯
ERCC-00058b 11 D ◯[1,2] ◯ ◯ ◯
ERCC-00069 11 E ◯ ◯
ERCC-00044 12 B ◯ ◯
ERCC-00025 14 A ◯
ERCC-00028 14 B ◯
ERCC-00040 14 C ◯
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The spread of the data indicates that differences in
signals observed between different RNA species
within the same sample may not accurately reflect the
relative abundance between different RNA compo-
nents of the same sample. Some of this dispersion
may be due to the complexity of the pools used in
these experiments where the distribution of target
abundances described in Table 1 may not have been
attained. For microarrays, probe designs for each
ERCC target may also introduce some variability in
signal between different ERCC controls at the same
relative abundance. For RNA-Seq, a non-uniform dis-
tribution of reads along different control sequences
may also contribute to the variability [17].
The ERCC controls did demonstrate that there is a
linear region of the dynamic range of each platform
where changes in abundance of a particular RNA tran-
script can produce a proportional change in signal. In this
region, the ratios obtained with each platform approach
the target ratios of the modified Latin square design. As a
consequence, comparisons between samples for any
particular RNA species can be expected to be accurate
with respect to ratio-based measurements if they fall
within this region. A pair of complex mixtures of
RNA controls derived from NIST SRM 2374 designed
to provide a set of ratios across a similar dynamic
range is commercially available (Ambion™ ERCC
ExFold RNA Spike-In Mixes). NIST has developed an
R-based tool, the erccdashboard, to provide metrics
and visualizations for these controls [18].
The ERCC RNA controls demonstrated utility in four
different gene expression microarray platforms and two
RNA-Seq platforms. Performance issues with any indi-
vidual ERCC could be attributed to detection limitations
or a target probe issue for particular platforms. The
spike-in RNA controls were useful for establishing the
dynamic range of relative abundance for a platform as
well as delineating a reliable region where ratios can be
measured accurately.
The composite testing scheme used in this study dem-
onstrated that using well-designed pools of RNA con-
trols provides measurement assurance for endogenous
gene expression studies. Pools of RNA controls from this
study have been used as spike-ins for RNA-Seq experi-
ments [19], and commercially available versions of these
controls have been used for their intended purpose as
quality controls [20–23]. These controls have also
proven useful in product and method development due
to their certified sequences and known concentrations
[24–32]. Recently, they have become important in com-
paring transcriptomes between cell types in immunology
[20, 32, 33], agriculture [34, 35], and other biology
studies [21, 36–38], as well as key to understanding
and accounting for the technical noise in single-cell
sequencing studies [39–42].
Additional files
Additional file 1: Figure S1. Bland-Altman plot of each pair-wise pool
comparison using the Illumina microarray platform. Symbols correspond
to pools A-E (see Fig. 1). Filled circles = A, open circles = B, open diamonds
= C, open triangles = D, and open squares = E. The red line corresponds to
the ratio versus average intensity derived from the fitted Langmuir model.
(PDF 249 kb)
Additional file 2: Figure S2. Bland-Altman plot of each pair-wise pool
comparison using the NIAID microarray platform. See Additional file 1:
Figure S1 legend. (PDF 262 kb)
Additional file 3: Figure S3. Bland-Altman plot of each pair-wise pool
comparison using the Agilent 1-color microarray platform. See Additional
file 1: Figure S1 legend. (PDF 279 kb)
Additional file 4: Figure S4. Bland-Altman plot of each pair-wise pool
comparison using the Agilent 2-color microarray platform. See Additional
file 1: Figure S1 legend. (PDF 270 kb)
Additional file 5: Figure S5. Bland-Altman plot of each pair-wise pool
comparison using the LifeTech NGS platform. Symbols correspond to
subpools A-E (see Fig. 1). Filled circles = A, open circles = B, open
diamonds = C, open triangles = D, and open squares = E. (PDF 186 kb)
Additional file 6: Figure S6. Bland-Altman plot of each pair-wise pool
comparison using the Illumina NGS platform. See Additional file 5: Figure S5
legend. (PDF 172 kb)
Table 3 ERCC outliers grouped by performance criteria (Continued)
ERCC-00042 14 E ◯ ◯
ERCC-00007 16 D ◯
ERCC-00022 16 C ◯[1,2]
ERCC-00170b 16 A ◯[2] ◯ ◯ ◯
ERCC-00023 18 D ◯[1,2]
ERCC-00002 20 B ◯
ERCC-00012 20 A ◯
ERCC-00024 20 E ◯[1,2]
The following analytes were incorrectly prepared as their antisense sequence and omitted from the data anlysis: ERCC-00009, ERCC-00014, ERCC-00057, ERCC-
00059, ERCC-00099, ERCC-00108, and ERCC-00116
aNumbers in bracket indicate array type: 1 = Agilent 1-color, 2 = Agilent 2-color
bDiscussed further in main text
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Additional file 7: Illumina bead ERCC controls data in comma-separated
values (CSV) format. (CSV 15 kb)
Additional file 8: NIAID microarray ERCC controls data in comma-
separated values (CSV) format. (CSV 15 kb)
Additional file 9: Agilent 1-color ERCC controls data in comma-
separated values (CSV) format. (CSV 14 kb)
Additional file 10: Agilent 2-color ERCC controls data in comma-
separated values (CSV) format. (CSV 14 kb)
Additional file 11: LifeTech NGS ERCC controls data in comma-
separated values (CSV) format. (CSV 7 kb)
Additional file 12: Illumina NGS ERCC controls data in comma-
separated values (CSV) format. (CSV 9 kb)
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sequencing; LifeTech, Life Technologies; NGS, next-generation sequencing;
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